Nicholas Khadder - 31 May 2022 Form 4 Insider Report for STANDARD BIOTOOLS INC. (LAB)

Reporting relationship: SVP, Gen. Counsel & Secretary
Issuer ticker: LAB
Reported as of: 31 May 2022
Net transaction value: +$5,369
SEC form: 4
Accepted by SEC: 03 Jun 2022, 18:01:31 UTC
Prior SEC filing: 23 May 2022
Next SEC filing: 12 Aug 2022
Source filing: View source filing
Reporting owner signature: /s/ Nicholas Khadder

Key filing fact

Nicholas Khadder filed Form 4 for STANDARD BIOTOOLS INC. (LAB) on 03 Jun 2022.

Key facts

This page summarizes Nicholas Khadder's Form 4 filing for STANDARD BIOTOOLS INC. (LAB).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 03 Jun 2022, 18:01.

Change

Previous filing in this sequence was filed on 23 May 2022.
Current net transaction value: +$5,369.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

LAB transaction

Common Stock

Award

Transaction value: $5,369
Shares: +3,341
Change %: +3.4%
Price: $1.61
Shares after: 100,480
Date: 31 May 2022
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

These shares were acquired under the Standard BioTools 2017 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c).